VEVYE FDA approval date

The FDA approved VEVYE on 30 May 2023.

FDA approval date
30 May 2023

Drug identity has not yet been verified against registry records

Also recorded as CYCLOSPORINE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-05-30DayVEVYEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217469", "applicant_as_listed_by_fda": "HARROW EYE", "brand_names": ["VEVYE"], "active_ingredients": ["CYCLOSPORINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230530", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026